Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system (Q34549418)

7 June 2018

title

Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system (English)

1 reference

7 June 2018

author

Emanuel Raschi

3

1 reference

7 June 2018

author name string

Gabriela Mazzanti

1

1 reference

7 June 2018

Paola Angela Moro

2

1 reference

7 June 2018

Roberto Da Cas

4

1 reference

7 June 2018

Francesca Menniti-Ippolito

5

1 reference

7 June 2018

language of work or name

English

0 references

publication date

19 January 2017

1 reference

7 June 2018

British Journal of Clinical Pharmacology

published in

1 reference

7 June 2018

volume

83

1 reference

7 June 2018

issue

4

1 reference

7 June 2018

page(s)

894-908

1 reference

7 June 2018

Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Systematic Review of Adverse Effects from Herbal Drugs Reported in Randomized Controlled Trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Systematic review of red yeast rice compared with simvastatin in dyslipidaemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

The Concise Guide to PHARMACOLOGY 2015/16: Enzymes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Emergency Department Visits for Adverse Events Related to Dietary Supplements.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Red yeast rice for the treatment of dyslipidemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Review of red yeast rice content and current Food and Drug Administration oversight

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Herbal hepatotoxicity: a critical review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Case definition and phenotype standardization in drug-induced liver injury.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

The role of red yeast rice for the physician

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Toxicological properties of citrinin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Symptomatic hepatitis associated with the use of herbal red yeast rice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Surveillance of suspected adverse reactions to natural health products in Italy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Anecdotes that provide definitive evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Symptomatic myopathy due to red yeast rice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Chinese red rice-induced myopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Pharmacovigilance of herbal medicines : a UK perspective

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Adverse drug reactions: definitions, diagnosis, and management

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5346868

Constituents of red yeast rice, a traditional Chinese food and medicine

7 July 2018

1 reference

Lipid-lowering efficacy of red yeast rice in a population intolerant to statins

21 January 2018

1 reference

Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.

21 January 2018

1 reference

Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.

21 January 2018

1 reference

New monascus metabolite isolated from red yeast rice (angkak, red koji).

21 January 2018

1 reference

[Red yeast-rice-induced muscular injuries: Analysis of French pharmacovigilance database and literature review].

21 January 2018

1 reference

A case report of myopathy from consumption of red yeast rice.

21 January 2018

1 reference

Low-dose venlafaxine-induced severe rhabdomyolysis: a case report.

21 January 2018

1 reference

Anaphylaxis to proton pump inhibitors.

21 January 2018

1 reference

Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing

21 January 2018

1 reference

Statins and "chameleon-like" cutaneous eruptions: simvastatin-induced acral cutaneous vesiculobullous and pustular eruption in a 70-year-old man.

21 January 2018

1 reference

Prevalence and characteristics of vitamin or dietary supplement users in Lausanne, Switzerland: the CoLaus study.

21 January 2018

1 reference

The use of dietary supplements among older persons in Southern Germany — Results from the KORA-age study

21 January 2018

1 reference

Chemical profiling and quantification of monacolins and citrinin in red yeast rice commercial raw materials and dietary supplements using liquid chromatography-accurate QToF mass spectrometry: Chemometrics application

21 January 2018

1 reference

Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins

21 January 2018

1 reference

12 December 2020

Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series

1 reference

12 December 2020

Omeprazole-induced drug reaction with eosinophilia and systemic symptoms (DRESS)

1 reference

12 December 2020

[Hepatitis associated with treatment with lovastatin. Presentation of 2 cases]

1 reference

12 December 2020

Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge

1 reference

12 December 2020

Adverse reactions in the skin from anti-hypertensive drugs

1 reference

12 December 2020

Safety and tolerability of the use of atorvastatin 40 mg in common daily practice in short-term observation in 3,227 patients

1 reference

12 December 2020

Identifiers

DOI

10.1111/BCP.13171

1 reference

7 June 2018

PMCID

5346868

1 reference

7 June 2018

PubMed ID

28093797

1 reference

7 June 2018